The North America continuous glucose monitoring (CGM) market was valued at USD 6.56 Billion in 2024 and is projected to reach USD 25.41 Billion by 2034, growing at a CAGR of 14.50%. This growth is fueled by increasing diabetes prevalence and ongoing technological advancements across the region. https://www.expertmarketresearch.com/reports/north-america-continuous-glucose-monitoring-market